Product Description
Sodium ascorbate is an organic sodium salt resulting from the replacement of the proton from the 3-hydroxy group of ascorbic acid by a sodium ion. It has a role as a food antioxidant, a flour treatment agent, a coenzyme, a plant metabolite, a human metabolite, a Daphnia magna metabolite and a reducing agent. It is an organic sodium salt and a vitamin C. It contains a L-ascorbate. (Sourced from: https://pubchem.ncbi.nlm.nih.gov/compound/Sodium-ascorbate)
Mechanisms of Action: Iron Inhibitor
Novel Mechanism: No
Modality: Small Molecule
Route of Administration: Intravenous, Oral
FDA Designation: *
Approval Status: Not Approved
Approved Countries: Algeria | Australia | Austria | Belgium | Brazil | Chile | China | Colombia | Croatia | Cyprus | Dominican Republic | Ecuador | Egypt | Estonia | Finland | France | Greece | Hong Kong | Hungary | India | Indonesia | Ireland | Malaysia | Malta | Mexico | Morocco | Norway | Pakistan | Philippines | Poland | Russia | Serbia | South Africa | Spain | Sweden | Taiwan | Ukraine | United Arab Emirates | United Kingdom | United States | Vietnam
Approved Indications: None
Known Adverse Events: None
Company: Norgine
Company Location:
Company CEO:
Additional Commercial Interests: None
Clinical Description
Countries in Clinic: Italy, United States
Active Clinical Trial Count: 2
Recent & Upcoming Milestones
Highest Development Phases
Phase 3: Other
Phase 1: Acinar Cell Carcinoma|Adenocarcinoma|Breast Cancer|Ductal Breast Carcinoma|Pancreatic Cancer|Pancreatic Ductal Carcinoma
Trial ID |
Trial |
Phase |
Trial Status |
Disease |
Primary Completion Date |
Probability of Success |
Latest Trial Update Date |
Data Updated |
|---|---|---|---|---|---|---|---|---|
NCT04150042 |
SHARON | P1 |
Recruiting |
Adenocarcinoma|Pancreatic Cancer|Ductal Breast Carcinoma|Pancreatic Ductal Carcinoma|Acinar Cell Carcinoma|Breast Cancer |
2028-12-01 |
50% |
2026-01-30 |
Patient Enrollment|Primary Completion Date|Primary Endpoints|Study Completion Date|Treatments |
2025-522046-42-00 |
NER1006-01/2025 | P3 |
Not yet recruiting |
Other |
2027-01-06 |
10% |
Recent News Events
Date |
Type |
Title |
|---|---|---|
|
10/11/2023 |
News Article |
Vitamin C Market Analytical Report 2023 to 2032 - Top Players Abbott Laboratories, CSPC Pharma, North China Pharma, DuPont |
|
09/28/2023 |
News Article |
Vitamin C Market Set to Witness Unprecedented Growth of USD 48.62 Billion by 2030, Size, Share, Trends, Growth Opportunities and Competitive Outlook |
|
09/25/2023 |
News Article |
Heat and Moisture Exchangers (HME) Market Growth and Opportunities [2023 - 2030] |
|
09/25/2023 |
News Article |
Sodium Ascorbate Market Research Report 2023-2031 |